News and Comments

The Sky’s The Limit For Micromet’s BiTE Technology’s Capability

  Tuesday, July 19, 2011

Micromet (MITI) added another important collaborator, Amgen (AMGN), to a long list of large and small drug developing companies that are attracted to Micromet’s BiTE technology. Amgen/Micromet agreement looks fair for both. It fits Amgen’s strategy of focusing on adding next-generation products to its pipeline and helps Micromet’s financial requirements during the development of its promising proprietary cancer programs. Amgen wanted to select from among three BiTE-based drugs against three undisclosed solid tumor targets. The giant biotech will pay upfront, milestone, and other payments in a deal that could be worth over $900 million for the two selected drugs, or half of this amount if it selects only one drug, in addition to double-digit royalties in the event of approvals and sales. More...


Recent Postings


Archive


Tags

C4 Therapeutics Xoma (XOMA) Ariad (ARIA) REGULUS (RGLS) ARGOS (ARGS) KITE (KITE) Anacor (ANAC) Bellicum (BLCM) Exelixis (EXEL) Zerenex Amgen (AMGN) CompuGen (CGEN) galapagos (GLPG) BIOMARIN (BMRN) Intrexon (XON) OSI (OSIP) Global Cell Therapeutics (GBT) Biocryst (BCRX) IDERA (IDRA) Editas (EDIT) Alnylam (ALNY) Onyx (ONXX) Intermune (ITMN) Galena (GALE) Incyte (INCY) Micromet (MITI) Aimmune Therapeutics (AIMT) Rapamune PTC Therapeutics (PTCT) Ocular Therapeutix (OCUL) Auspex (ASPX) Ionis (IONS) HALOZYME (HALO) ImmunoGen (IMGN) Trastuzumab-DM1 NOVOCURE (NVCR) Roche (RHHBY) Velcade (bortezomib) RenenxBio (RGNX) CRISPR Therapeutics (CRSP) Alder Biopharmaceuticals (ALDR) Tysabri Biogen Idec (BIIB) Sanofi-Aventis (SAN) NANTKWEST (NK) Regeneron (REGN) SUNESIS PHARMACEUTICALS (SNSS) Ziofpharm (ZIOP) Multiple Myeloma Telaprevir Gilead (GILD) GUARDIAN HEALTH AERIE PHARMACEUTICALS Roche (ROCHE) KERYX (KERX) VANDA (VNDA) Inovio (INO) Human Longevity (HLI) Herceptin Dynavax (DVAX) MODERNA Sarepta (SRPT) AstraZeneca (AZN) Merck (MRK) Agenus (AGEN Sanofi (SNA) Advaxis (ADXS) Pluristem (PSTI) Benlysta (belimumab) AGOS (ARGS) INNOVIVA (INVA) Jazz Pharmaceuticals (JAZZ) Vitae Pharmaceuticals (VTAE) CEMPRA (CEMP) SERES THERAPEUTICS (MCRB) SYNTA (SNTA) Ridaforolimus Vertex (VRTX) Agenus (AGEN) Genentech Array Pharmaceuticals (ARRY) Prolor Biotech (PBTH) Anadys (ANDS) Spike Therapeutics (ONCE) Bristol-Myers Squibb (BMY) Revlimid (lenolidamide) Valeant Pharmaceuticals International (VRX) JUNO (JUNO) Prosensa (RNA) Abbott Laboratories (ABT) Mirati Therapeutics (MRTX) ARCA (ABIO) Adaptimmune (ADAP) Sanofi (SNY) ADVENTRIX (ANX) Dendreon (DNDN) GlaxoSmithKline (GSK) PORTOLA (PTLA) ABBVIE (ABBV) Sangamo (SGMO) Human Genome Sciences (HGSI) ISIS (ISIS) Idenix (IDIX) Elan (ELN) ACADIA (ACAD) Theravance (THRX) Illumina (ILMN) NEKTAR (NKTR)) ZALTRAP™ Sequenom (SQNM) Intercept (ICPT) Cytokinetics (CYTK) Seattle Genetics (SGEN) TOKAI (TKAOI) Theravance Bio Pharma (TBPH) Endometrial Cancer